Bicifadine (DOV-220075) is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) developed by DOV Pharmaceutical. It has been developed as an analgesic and is currently under development for the treatment of various pain conditions.
This page contains content from the copyrighted Wikipedia article "Bicifadine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.